Add to ORKGOsteoporosis and atherosclerosis are linked by biological association. This encourages the search for therapeutic strategies having both cardiovascular and skeletal beneficial effects. Among drugs that may concordantly enhance bone density and reduce the progression of atherosclerosis we can include bisphosphonates (BP), statins, b-blockers, and possibly anti-RANKL antibodies. Available data come from experimental animals and human studies. All these treatments however lack controlled clinical studies designed to demonstrate dualaction effects
Background Osteoporosis and cardiovascular disease are interconnected entities with pathophysiologic...
BACKGROUND: Bisphosphonates (BPs), the gold-standard pharmacological treatment for osteoporosis, are...
Osteoporosis and atherosclerosis are chronic degenerative diseases which have been considered to be ...
Background: Epidemiologic and clinical data have suggested the existence of a biologic linkage betwe...
Background: Epidemiologic and clinical data have suggested the existence of a biologic linkage betwe...
Background: Epidemiologic and clinical data have suggested the existence of a biologic linkage betwe...
In the second part of the literature review, data are presented on the possible effect of anti-osteo...
Carla Caffarelli,1 Andrea Montagnani,2 Ranuccio Nuti,1 Stefano Gonnelli1 1Department of Medicine, S...
Osteoporosis and cardiovascular (CV) disease share common risk factors and pathophysiology. Low bone...
The majority of scientific research data promote the idea that OP and Atherosclerosis are inter-conn...
ABSTRACT Osteoporosis and cardiovascular (CV) disease share common risk factors and pathophysiology....
The commonest medical conditions following menopause are osteoporosis and atherosclerotic disease. T...
Daily use of antihypertensive and lipid-lowering drugs in clinical practice dictates the need for kn...
The commonest medical conditions following menopause are osteoporosis and atherosclerotic disease. T...
The commonest medical conditions following menopause are osteoporosis and atherosclerotic disease. T...
Background Osteoporosis and cardiovascular disease are interconnected entities with pathophysiologic...
BACKGROUND: Bisphosphonates (BPs), the gold-standard pharmacological treatment for osteoporosis, are...
Osteoporosis and atherosclerosis are chronic degenerative diseases which have been considered to be ...
Background: Epidemiologic and clinical data have suggested the existence of a biologic linkage betwe...
Background: Epidemiologic and clinical data have suggested the existence of a biologic linkage betwe...
Background: Epidemiologic and clinical data have suggested the existence of a biologic linkage betwe...
In the second part of the literature review, data are presented on the possible effect of anti-osteo...
Carla Caffarelli,1 Andrea Montagnani,2 Ranuccio Nuti,1 Stefano Gonnelli1 1Department of Medicine, S...
Osteoporosis and cardiovascular (CV) disease share common risk factors and pathophysiology. Low bone...
The majority of scientific research data promote the idea that OP and Atherosclerosis are inter-conn...
ABSTRACT Osteoporosis and cardiovascular (CV) disease share common risk factors and pathophysiology....
The commonest medical conditions following menopause are osteoporosis and atherosclerotic disease. T...
Daily use of antihypertensive and lipid-lowering drugs in clinical practice dictates the need for kn...
The commonest medical conditions following menopause are osteoporosis and atherosclerotic disease. T...
The commonest medical conditions following menopause are osteoporosis and atherosclerotic disease. T...
Background Osteoporosis and cardiovascular disease are interconnected entities with pathophysiologic...
BACKGROUND: Bisphosphonates (BPs), the gold-standard pharmacological treatment for osteoporosis, are...
Osteoporosis and atherosclerosis are chronic degenerative diseases which have been considered to be ...